27 related articles for article (PubMed ID: 34617446)
1. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
2. Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound.
Xu S; Huang H; Xian K; Wang X; Xu Z; Liu S; Liu J
Endocrine; 2024 May; ():. PubMed ID: 38703328
[TBL] [Abstract][Full Text] [Related]
3. The relationship of pre-operative vitamin D and TSH levels with papillary thyroid cancer.
Unlu MT; Aygun N; Caliskan O; Isgor A; Uludag M
North Clin Istanb; 2023; 10(6):697-703. PubMed ID: 38328719
[TBL] [Abstract][Full Text] [Related]
4. Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study).
Lee JK; Ku EJ; Kim SJ; Kim W; Cho JW; Jung KY; Yu HW; Kang YE; Kim M; Kim HK; Ryu J; Choi JY;
Ann Surg Treat Res; 2024 Jan; 106(1):19-30. PubMed ID: 38205091
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
Gunn AH; Frisco N; Thomas SM; Stang MT; Scheri RP; Kazaure HS
Thyroid; 2022 Jan; 32(1):54-64. PubMed ID: 34663089
[No Abstract] [Full Text] [Related]
6. Dynamic risk assessment in patients with differentiated thyroid cancer.
Abelleira E; Jerkovich F
Rev Endocr Metab Disord; 2024 Feb; 25(1):79-93. PubMed ID: 38015344
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy.
Gigliotti BJ; Jasim S
Endocrine; 2024 Feb; 83(2):251-258. PubMed ID: 37824045
[TBL] [Abstract][Full Text] [Related]
8. Initial ablation ratio predicts the recurrence of low-risk papillary thyroid microcarcinomas treated with microwave ablation: a 5-year, single-institution cohort study.
Ren Y; Han X; Li Y; Chen G; Jiang L; Liu C; Xu S
Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37467003
[TBL] [Abstract][Full Text] [Related]
9. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
Ullmann TM; Papaleontiou M; Sosa JA
J Clin Endocrinol Metab; 2023 Jan; 108(2):271-280. PubMed ID: 36327392
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
[TBL] [Abstract][Full Text] [Related]
11. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.
Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY
Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317
[TBL] [Abstract][Full Text] [Related]
12. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
13. Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis.
Won HR; Jeon E; Chang JW; Kang YE; Song K; Kim SW; Lim DM; Ha TK; Chung KW; Kim HJ; Park YJ; Koo BS
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326621
[TBL] [Abstract][Full Text] [Related]
14. Optimal Serum Thyrotropin Level for Patients with Papillary Thyroid Carcinoma After Lobectomy.
Xu S; Huang Y; Huang H; Zhang X; Qian J; Wang X; Xu Z; Liu S; Liu J
Thyroid; 2022 Feb; 32(2):138-144. PubMed ID: 34617446
[No Abstract] [Full Text] [Related]
15. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation.
Li X; Yan L; Xiao J; Li Y; Zhu Y; Yang Z; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2160880. PubMed ID: 36599433
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
